Creative Capital Management Investments’s Vaxcyte PCVX Stock Holding History

Creative Capital Management Investments’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407	Buy	+7	New	+$380	﹤0.01%	1312

Other funds holding PCVX

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Creative Capital Management Investments's PCVX Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Vaxcyte (PCVX) in Q2 2026: 7 shares worth $407. The stake represents ﹤0.01% of the portfolio and ranks #1312 among its holdings.

37 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Creative Capital Management Investments held 7 shares of Vaxcyte worth $407 as of Q2 2026.
Vaxcyte was a new Creative Capital Management Investments position in Q2 2026.
Vaxcyte made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1312 holding.
37 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.